SEARCH

SEARCH BY CITATION

References

  • Abercrombie M. (1946) Estimation of nuclear population from microtome sections. Anat. Rec. 4, 239247.
  • Agrawal A. K., Shukla S., Chaturvedi R. K., Seth K., Srivastava N., Ahmad A. and Seth P. K. (2004a) Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson’s disease: a cotransplantation approach with fetal ventral mesencephalic cells. Neurobiol Dis. 16, 516526.
  • Agrawal A. K., Chaturvedi R. K., Shukla S., Seth K., Chauhan S., Ahmad A. and Seth P. K. (2004b) Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson’s disease. J. Chem. Neuroanat. 28, 253264.
  • Akerud P., Canals J. M., Snyder E. Y. and Arenas E. (2001) Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson’s disease. J. Neurosci. 21, 81088118.
  • Alexi T., Borlongan C. V., Faull R. L., Williams C. E., Clark R. G., Gluckman P. D. and Hughes P. E. (2000) Neuroprotective strategies for basal ganglia degeneration: Parkinson’s and Huntington’s diseases. Prog. Neurobiol. 60, 409470.
  • Aszmann O. C., Korak K. J., Kropf N., Fine E., Aebischer P. and Frey M. (2002) Simultaneous GDNF and BDNF application leads to increased motor-neuron survival and improved functional outcome in an experimental model for obstetric brachial plexus lesions. Plast. Reconstr. Surg. 110, 10661072.
  • Au E., Richter M. W., Vincent A. J., Tetzlaff W., Aebersold R., Sage E. H. and Roskams A. J. (2007) SPARC from olfactory ensheathing cells stimulates Schwann cells to promote neurite outgrowth and enhances spinal cord repair. J. Neurosci. 27, 72087221.
  • Benedetti S., Pirola B., Pollo B. et al. (2000) Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6, 447450.
  • Blochl A. and Sirrenberg C. (1996) Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J. Biol. Chem. 271, 2110021107.
  • Carvey P. M., Ling Z. D., Sortwell C. E., Pitzer M. R., McGuire S. O., Storch A. and Collier T. J. (2001) A clonal line of mesencephalic progenitor cells converted to dopamine neurons by hematopoietic cytokines: a source of cells for transplantation in Parkinson’s disease. Exp. Neurol. 171, 98108.
  • Chaturvedi R. K., Agrawal A. K., Seth K., Shukla S., Chauhan S., Shukla Y., Sinha C. and Seth P. K. (2003) Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson’s disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 21, 391400.
  • Chaturvedi R. K., Shukla S., Seth K. and Agrawal A. K. (2006a) Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson’s disease. Neurosci. Lett. 398, 4449.
  • Chaturvedi R. K., Shukla S., Seth K., Chauhan S., Sinha C., Shukla Y. and Agrawal A. K. (2006b) Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease. Neurobiol Dis. 22, 421434.
  • Chaturvedi R. K., Shukla S., Seth K. and Agrawal A. K. (2008) Zuckerkandl’s organ improves long-term survival and function of neural stem cell derived dopaminergic neurons in Parkinsonian rats. Exp. Neurol. 210, 608623.
  • Chiang Y., Morales M., Zhou F. C., Borlongan C., Hoffer B. J. and Wang Y. (2001) Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats. Brain Res. 889, 200207.
  • Dewar D., Bentley D. and Barnett S. C. (2007) Implantation of pure cultured olfactory ensheathing cells in an animal model of parkinsonism. Acta Neurochir (Wien). 149, 407414.
  • Doucette R. (1990) Glial influences on axonal growth in the primary olfactory system. Glia. 3, 433449.
  • Erickson J. T., Brosenitsch T. A. and Katz D. M. (2001) Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. J. Neurosci. 21, 581589.
  • Fairless R. and Barnett S. C. (2005) Olfactory ensheathing cells: their role in central nervous system repair. Int. J. Biochem. Cell Biol. 37, 693699.
  • Gage F. H. (2000) Mammalian neural stem cells. Science 287, 14331438.
  • Granholm A.-C., Henry S., Hebert M. A., Eken S., Gerhardt G. A. and Horne C. V. (1998) Kidney co-grafts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery. Cell Transplant. 7, 197212.
  • Hagg T. (1998) Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp. Neurol. 149, 183192.
  • Hagg T. and Varon S. (1993) Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA, 90, 63156319.
  • Johansson S., Lee I.-Hui., Olson L. and Spenger C. (2005) Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions. Brain 128, 29612976.
  • Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104111.
  • Kondo J., Kitamura Y., Inden M. and Taniguchi T. (2004) Hemiparkinsonian rat models: different sensitivity of dopaminergic neurotoxins. Int. Cong. Series. 260, 281285.
  • Lee C. S., Cenci M. A., Schulzer M. and Bjorklund A. (2000) Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson’s disease. Brain. 2000, 13651379.
  • Lindvall O., Kokaia Z. and Martinez-Serrano A. (2004) Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10, S42S50.
  • Mackay-Sim A. (2005) Olfactory ensheathing cells and spinal cord repair. Keio J. Med. 54, 814.
  • Melchior B., Nerriere-Daguin V., Laplaud D. A., Remy S., Wiertlewski S., Neveu I., Naveilhan P., Meakin S. O. and Brachet P. (2003) Ectopic expression of the TrkA receptor in adult dopaminergic mesencephalic neurons promotes retrograde axonal NGF transport and NGF-dependent neuroprotection. Exp. Neurol. 183, 367378.
  • Monje M. L., Toda H. and Palmer T. D. (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302, 17601765.
  • Mufson E. J., Kroin J. S., Sendera T. J. and Sobreviela T. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451484.
  • Nash H. H., Borke R. C. and Anders J. J. (2001) New method of purification for establishing primary cultures of ensheathing cells from the adult olfactory bulb. Glia. 34, 8187.
  • Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M. G. and Bjorklund A. A. (1994) microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63, 5772.
  • Nishimura F., Yoshikawa M., Kanda S. et al. (2003) Potential use of embryonic stem cells for the treatment of mouse Parkinsonian models: improved behavior by transplantation of in vitro differentiated dopaminergic neurons from embryonic stem cells. Stem Cells. 21, 171180.
  • Olanow C. W., Goetz C. G., Kordower J. H. et al. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann. Neurol. 54, 403414.
  • Ostenfeld T., Joly E., Tai Y. T., Peters A., Caldwell M., Jauniaux E. and Svendsen C. N. (2002) Regional specification of rodent and human neurospheres. Brain Res. Dev. Brain Res. 134, 4355.
  • Ourednik V., Ourednik J., Park K. I., Teng Y. D., Aboody K. A., Auguste K. I., Taylor R. M., Tate B. A. and Snyder E. Y. (2000) Neural stem cells are uniquely suited for cell replacement and gene therapy in the CNS. Novartis Found. Symp. 231, 242262.
  • Ourednik J., Ourednik V., Lynch W. P., Schachner M. and Snyder E. Y. (2002) Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20, 11031110.
  • Palfi S., Leventhal L., Chu Y., Ma S. Y., Emborg M., Bakay R., Deglon N., Hantraye P., Aebischer P. and Kordower J. H. (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J. Neurosci. 22, 49424954.
  • Paxinos G. and Watson C., eds (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, California, USA.
  • Pearse D. D., Sanchez A. R., Pereira F. C. et al. (2007) Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia. 55, 9761000.
  • Pellitteri R., Spatuzza M. and Russo A. (2007) Stanzani S.Olfactory ensheathing cells exert a trophic effect on the hypothalamic neurons in vitro. Neurosci. Lett. 417, 2429.
  • Pluchino S., Zanotti L., Deleidi M. and Martino G. (2005) Neural stem cells and their use as therapeutic tool in neurological disorders. Brain Res. Brain Res. Rev. 48, 211219.
  • Ramon-Cueto A. and Nieto-Sampedro M. (1992) Glial cells from adult rat olfactory bulb: immunocytochemical properties of pure cultures of ensheathing cells. Neuroscience 47, 213220.
  • Ramon-Cueto A., Plant G. W., Avila J. and Bunge M. B. (1998) Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J. Neurosci. 18, 38033815.
  • Richter M. W. and Roskams A. J. (2008) Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope? Exp. Neurol. 209, 353367.
  • Rosenblad C., Martinez-Serrano A. and Bjorklund A. (1998) Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson’s disease. Neuroscience 82, 129137.
  • Rothstein J. D. and Snyder E. Y. (2004) Reality and immortality--neural stem cells for therapies. Nat Biotechnol. 22, 283285.
  • Roy A., Agrawal A. K., Husain R., Dubey M. P. and Seth P. K. (1999) Cholinergic and serotonergic alterations in the rat hippocampus following trimethyltin exposure and fetal neural transplantation. Neurosci. Lett. 259, 173176.
  • Salinas M., Diaz R., Abraham N. G., Ruiz de Galarreta C. M. and Cuadrado A. (2003) Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278, 1389813904.
  • Schumm M. A., Castellanos D. A., Frydel B. R. and Sagen J. (2004) Improved neural progenitor cell survival when cografted with chromaffin cells in the rat striatum. Exp. Neurol. 185, 133142.
  • Shimoke K. and Chiba H. (2001) Nerve growth factor prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced cell death via the Akt pathway by suppressing caspase-3-like activity using PC12 cells: relevance to therapeutical application for Parkinson’s disease. J. Neurosci. Res. 63, 402409.
  • Shingo T., Date I., Yoshida H. and Ohmoto T. (2002) Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson’s disease. J. Neurosci. Res. 69, 946954.
  • Shukla S., Agrawal A. K., Chaturvedi R. K., Seth K., Srivastava N., Sinha C., Shukla Y., Khanna V. K. and Seth P. K. (2004) Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine lesioned rats: implications for Parkinson’s disease. J. Neurochem. 91, 274284.
  • Slevin J. T., Gerhardt G. A., Smith C. D., Gash D. M., Kryscio R. and Young B. (2005) Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102, 216222.
  • Snyder B. J. and Olanow C. W. (2005) Stem cell treatment for Parkinson’s disease: an update for 2005. Curr. Opin. Neurol. 18, 376385.
  • Song H. J., Stevens C. F. and Gage F. H. (2002) Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat. Neurosci. 5, 438445.
  • Storch A., Lester H. A., Boehm B. O. and Schwarz J. (2003) Functional characterization of dopaminergic neurons derived from rodent mesencephalic progenitor cells. J. Chem. Neuroanat. 26, 133142.
  • Stromberg I., Wetmore C. J., Ebendal T., Ernfors P., Persson H. and Olson L. (1990) Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF. J. Neurosci. Res. 25, 405411.
  • Studer L., Tabar V. and McKay R. D. (1998) Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1, 290295.
  • Takagi Y., Takahashi J., Saiki H. et al. (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest. 115, 102109.
  • Temple S. (2001) Stem cell plasticity--building the brain of our dreams. Nat. Rev. Neurosci. 2, 513520.
  • Toft A., Scott D. T., Barnett S. C. and Riddell J. S. (2007) Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain 130, 970984.
  • Wang X., Lu Y., Zhang H., Wang K., He Q., Wang Y., Liu X., Li L. and Wang X. (2004) Distinct efficacy of pre-differentiated versus intact fetal mesencephalon-derived human neural progenitor cells in alleviating rat model of Parkinson’s disease. Int. J. Dev. Neurosci. 22, 175183.
  • Weidner N., Blesch A., Grill R. J. and Tuszynski M. H. (1999) Nerve growth factor-hypersecreting Schwann cell grafts augment and guide spinal cord axonal growth and remyelinate central nervous system axons in a phenotypically appropriate manner that correlates with expression of L1. J. Comp. Neurol. 413, 495506.
  • Woodhall E., West A. K. and Chuah M. I. (2001) Cultured olfactory ensheathing cells express nerve growth factor, brain-derived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res. Mol. Brain Res. 88, 203213.
  • Yasuhara T., Shingo T., Muraoka K. et al. (2005) Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease. J. Neurosurg. 102, 8089.
  • Zawada W. M., Zastrow D. J., Clarkson E. D., Adams F. S., Bell K. P. and Freed C. R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786, 96103.